The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
3.440
+0.110 (3.30%)
At close: Apr 28, 2026, 4:00 PM EDT
3.365
-0.075 (-2.18%)
Pre-market: Apr 29, 2026, 6:00 AM EDT

Company Description

The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States.

It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other.

The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services.

It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies.

It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

The Oncology Institute, Inc.
The Oncology Institute logo
Country United States
Founded 2007
Industry Medical Care Facilities
Sector Healthcare
Employees 641
CEO Daniel Virnich

Contact Details

Address:
18000 Studebaker Road, Suite 800
Cerritos, California 90703
United States
Phone 562 735 3226
Website theoncologyinstitute.com

Stock Details

Ticker Symbol TOI
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001799191
CUSIP Number 68236X100
ISIN Number US68236X1000
Employer ID 84-3562323
SIC Code 8011

Key Executives

Name Position
Dr. Daniel Virnich FACHE, M.B.A., M.D. Chief Executive Officer and Executive Director
Dr. Yale D. Podnos F.A.C.S., M.D., M.P.H. Chief Medical Officer
Robert Carter Chief Financial Officer
Austin Lee Vice President of Accounting and Controller
Rakesh Panda Chief Information Officer
Kristin England Chief Administrative Officer
Minh Merchant Chief Legal Officer
Nolan Mariano Chief People Officer
Mark Hueppelsheuser Esq. General Counsel
Jordan McInerney Chief Development Officer

Latest SEC Filings

Date Type Title
Apr 28, 2026 ARS Filing
Apr 14, 2026 144 Filing
Mar 16, 2026 SCHEDULE 13G/A Filing
Mar 13, 2026 8-K Current Report
Mar 12, 2026 10-K Annual Report
Mar 12, 2026 8-K Current Report
Feb 23, 2026 8-K Current Report
Jan 15, 2026 SCHEDULE 13G Filing
Jan 12, 2026 8-K Current Report
Jan 7, 2026 8-K Current Report